Cover Story
Free
Brigham Doc's NEJM Paper Decries Morcellation's Demise—Did She Get Confidential Patient Information?
By Matthew Bin Han Ong
Update: The New England Journal of Medicine's subsequent response after this article is published is appended at the end.
In Brief
Drugs & Targets
Trending Stories
- What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.” - Trump 2016: A look back at the 45th president’s impact on oncology
- A study measures the long-term downside of prostate cancer screening
A paper in JAMA Oncology focuses on the harms of overscreening, overdiagnosis, and overtreatment - At an uncertain time for cancer research and public health, Wayne Frederick steps in as interim CEO at ACS
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation
- How the 2024 elections can impact cancer policy